Second, our research only explored one aspect of Tat-hspb1-induced ccRCC cell death, and further studies are needed to systematically investigate the molecules and pathways involved in Tat-hspb1-induced cell death. This evidence concerns the gene HSPB1 and nonpapillary renal cell carcinoma.